HAP Trading, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
HAP Trading, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$217,000
-32.0%
28,300
+44.4%
0.01%
+33.3%
Q4 2020$319,000
-82.9%
19,600
-88.2%
0.01%
-92.3%
Q4 2018$1,866,000
-0.3%
165,441
-56.6%
0.12%
+24.5%
Q4 2016$1,872,000
+1601.8%
381,507
+1426.0%
0.09%
+1780.0%
Q1 2014$110,000
-91.0%
25,000
+7.6%
0.01%
-86.8%
Q4 2013$1,222,00023,2320.04%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders